A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333 After Single Doses in Healthy Volunteers and After Single and Repeated Doses in Subjects With Bronchiectasis
Study Identifier:
CLI-06333CA1-01
ClinicalTrials.gov Identifier:
EudraCT Identifier:
N/A
Study Contact Information:
Recruiting
Study Details
Medical Condition
- Bronchiectasis
Study Drug
- Drug: CHF6333
- Drug: CHF6333 Placebo
Date
Nov 2023 - Jun 2025
Patient Requirements
Sex: Female & Male
Age: 18 - 80 Years
Requirements Information
Healthy Volunteers
Yes
Protocol Summary
The aim of this clinical trial is to assess the safety of: * single doses of the study drug CHF6333 in Healthy Volunteers (HVs) and in subjects with Bronchiectasis (BE) - Part I * repeated doses of the study drug CHF6333 in subjects with BE - Part II
Study Locations
Location
Status
Location
Royal Papworth Hospital NHS Foundation Trust, Cambridge Centre for Lung Infection
Cambridge, United Kingdom
Status
Not yet recruiting
Location
Tayside Medical Science Centre, Ninewells Hospital & Medical School
Dundee, United Kingdom
Status
Not yet recruiting
Location
NHS Lothian
Edinburgh, United Kingdom
Status
Not yet recruiting
Location
The Leeds Teaching Hospitals NHS Trust, Saint James's University Hospital
Leeds, United Kingdom
Status
Not yet recruiting
Location
Royal Bromptom Hospital (NHS Guy's and Thomas')
London, United Kingdom
Status
Not yet recruiting
Location
Manchester University NHS Foundation Trust
Manchester, United Kingdom
Status
Not yet recruiting